Kyverna Therapeutics Inc.

01/07/2025 | Press release | Distributed by Public on 01/07/2025 15:57

Robbins LLP Reminds Kyverna Therapeutics, Inc. Investors of the Pending Securities Fraud Class Action Against KYTX